BBOTVSEOCN• 6 Months (Normalized)
BBOT vs EOCN (BridgeBio Oncology Therapeutics Inc. vs Eocene Ltd.)
Showing Closing Date Range from Apr 10 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.5
-58.33%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
EOCN Performance $3.36
-3.72%
Eocene Ltd.
Normalized Baseline0.00%
Alpha Spread Margin EOCN LEADS
-54.61 pts
EOCN outperforming by 54.61 percentage points
BBOTEOCN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT EOCN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | BBOT Price | BBOT Gain (%) | EOCN Price | EOCN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.50 | -58.33% | $3.36 | -3.72% | -54.61% |
| Oct 05, 2026 | $3.60 | -57.14% | $3.45 | -1.15% | -55.99% |
| Oct 02, 2026 | $3.89 | -53.69% | $3.61 | +3.44% | -57.13% |
| Oct 01, 2026 | $- | $3.41 | -2.44% | - | |
| Sep 30, 2026 | $4.10 | -51.19% | $3.49 | +0.00% | -51.19% |
| Sep 29, 2026 | $3.92 | -53.33% | $- | - | |
| Sep 28, 2026 | $3.81 | -54.64% | $- | - | |
| Sep 25, 2026 | $3.95 | -52.98% | $- | - | |
| Sep 24, 2026 | $3.99 | -52.50% | $- | - | |
| Sep 23, 2026 | $4.16 | -50.48% | $- | - | |
| Sep 22, 2026 | $4.66 | -44.52% | $- | - | |
| Sep 21, 2026 | $4.66 | -44.52% | $- | - | |
| Sep 18, 2026 | $4.77 | -43.21% | $- | - | |
| Sep 17, 2026 | $4.89 | -41.79% | $- | - | |
| Sep 16, 2026 | $4.76 | -43.33% | $- | - |
Page 1 of 9